Special Senses & Otolaryngology

Chronic hearing loss: presbycusis and screening

Clinical Overview and When to Suspect Presbycusis

— Prevalence rises sharply with age: ~25% of adults 60–69, ~50% over 75, ~80% over 85

— Bilateral, symmetric, gradual, high-frequency SNHL from cumulative cochlear hair cell loss (especially outer hair cells at the basal turn), stria vascularis atrophy, and spiral ganglion degeneration

— Sensory (basal hair cell loss → steep high-frequency drop)

— Neural (spiral ganglion loss → poor word recognition out of proportion to audiogram)

— Strial/metabolic (flat loss, stria vascularis atrophy)

— Cochlear conductive (sloping loss from basilar membrane stiffening)

— Patient or family reports turning up TV volume, difficulty in restaurants/background noise, frequent "what?" or mishearing consonants (sh, f, s, th)

— Social withdrawal, apparent cognitive slowing, depression in an older adult

— Tinnitus (often bilateral, high-pitched) accompanying gradual hearing change

Board pearl: Presbycusis classically presents as difficulty understanding speech in noisy environments before pure-tone thresholds drop dramatically — high-frequency consonants carry meaning, vowels (low-frequency) carry volume, so patients say "I can hear you but can't understand you." This is the signature complaint distinguishing SNHL from conductive loss.

Presbycusis = age-related sensorineural hearing loss (SNHL), the most common sensory deficit in older adults

Pathophysiology subtypes (Schuknecht):

When to suspect in primary care:

Risk factors: age, male sex, noise exposure (occupational/military/recreational), ototoxic drugs (aminoglycosides, cisplatin, loop diuretics, high-dose ASA), smoking, diabetes, HTN, cardiovascular disease, genetics

Why it matters for Step 3: hearing loss is independently associated with incident dementia, falls, depression, and social isolation; treatment (hearing aids) reduces cognitive decline rate per ACHIEVE trial (2023) in at-risk older adults

Presentation Patterns and Key History

— "I hear but don't understand" — preserved volume perception, lost discrimination

— Difficulty with women's and children's voices (higher frequencies lost first)

— Trouble on the phone, in groups, in cars, places of worship

— Asking for repetition, mishearing similar-sounding words

— Tinnitus (60–90% of patients) — bilateral, continuous, high-pitched

— Presbycusis: gradual, symmetric, bilateral, over years

— Sudden SNHL (<72h): otologic emergency → urgent ENT, audiogram, consider oral steroids

— Asymmetric/unilateral progressive: rule out vestibular schwannoma with MRI internal auditory canal

— Fluctuating with vertigo and aural fullness: Ménière disease

— Onset, laterality, symmetry, progression rate, fluctuation

— Tinnitus, vertigo, otalgia, otorrhea, aural fullness

— Noise exposure: occupation (construction, military, musicians, factory), firearms, power tools, headphones at high volume

— Ototoxic drug review: aminoglycosides (gentamicin), platinum chemo, loop diuretics at high IV doses, chronic high-dose NSAIDs/ASA, quinine

— Family history of early hearing loss

— Cerumen symptoms, prior ear surgery, head trauma, recurrent otitis

— Comorbidities: DM, HTN, CKD, smoking, prior radiation to head/neck

— "Does a hearing problem cause you to feel embarrassed when meeting new people?"

— Score ≥10 → refer for audiometry

Step 3 management: When a 72-year-old reports gradual bilateral hearing trouble in restaurants, next best step is formal audiometry (pure-tone + speech), not empiric hearing aid referral or MRI — confirm the pattern first, then refer to audiology.

Hallmark complaints:

Tempo clues:

Targeted history (Step 3 outpatient flow):

Functional and screening questions ("Hearing Handicap Inventory for the Elderly – Screening" HHIE-S, 10 items):

Single-question screen: "Do you have difficulty with your hearing?" has sensitivity ~70–80%

Physical Exam Findings and Bedside Hearing Assessment

— Cerumen impaction (most common reversible cause in elderly) — irrigate or curette

— Tympanic membrane perforation, retraction, cholesteatoma

— Middle ear effusion (serous OM, eustachian tube dysfunction)

— Exostoses ("surfer's ear"), osteomas

— Signs of chronic otitis media or prior tympanoplasty

— Weber test: fork on vertex/forehead

— Lateralizes to affected ear = conductive loss in that ear

— Lateralizes to better ear = sensorineural loss in opposite ear

— Midline in symmetric presbycusis (both ears equally affected)

— Rinne test: fork at mastoid then external ear

— Normal/SNHL: AC > BC ("positive Rinne")

— Conductive loss (≥25 dB gap): BC > AC ("negative Rinne")

— Sensitivity 90–100%, specificity 70–87% for screening

Key distinction: In symmetric presbycusis, Weber is midline and Rinne is AC>BC bilaterally — the bedside exam can look "normal" despite significant high-frequency loss. Tuning forks at 512 Hz miss high-frequency SNHL; a normal Weber/Rinne does not rule out presbycusis and audiometry remains the gold standard when suspicion is present.

Otoscopy first — always exclude reversible causes before labeling presbycusis:

Bedside tuning fork tests (512 Hz):

Whispered voice test: examiner stands 2 ft behind patient, occludes opposite ear, whispers 3 letter-number combos; ≥3/6 correct = pass

Finger rub test: less reliable but quick

Cranial nerve and neurologic exam: facial nerve symmetry, gait, Romberg, Dix-Hallpike if vertigo

Cardiovascular exam: pulsatile tinnitus → auscultate neck/skull for bruits (consider AVM, glomus tumor, dural fistula)

Cognitive screen (Mini-Cog, MoCA) — but interpret cautiously; uncorrected hearing loss falsely lowers cognitive scores

Mood screen (PHQ-2/9) given strong link to depression and isolation

Diagnostic Workup — Audiometry and Initial Evaluation

— Tests air conduction (AC) and bone conduction (BC) at 250–8000 Hz in each ear

— Thresholds plotted; degree of loss:

— 0–25 dB normal

— 26–40 mild, 41–55 moderate, 56–70 moderately severe, 71–90 severe, >90 profound

— Presbycusis pattern: bilateral, symmetric, down-sloping high-frequency SNHL with AC=BC (no air–bone gap)

— Speech Reception Threshold (SRT) — softest level patient repeats 50% of spondee words

— Word Recognition Score (WRS / discrimination) — % correct at suprathreshold level

— Disproportionately poor WRS (e.g., <50% with mild loss) suggests retrocochlear lesion → MRI IAC

— Type A (normal middle ear) expected in presbycusis

— Type B (flat) = effusion or perforation

— Type C (negative pressure) = eustachian tube dysfunction

— Type As (shallow) = otosclerosis; Ad (deep) = ossicular discontinuity

— USPSTF (2021): insufficient evidence (I statement) to recommend for/against screening asymptomatic adults ≥50 — but case-finding by asking about hearing is universally endorsed

— AAFP echoes USPSTF; Medicare covers diagnostic audiology when ordered for symptoms, and as of 2023 covers direct access to audiologists for non-acute hearing assessments

— ASHA/AAO-HNS suggest periodic screening every decade in adults, every 3 years after age 50

Board pearl: A patient with mild audiometric loss but markedly poor word recognition has a retrocochlear pattern — order MRI internal auditory canal with gadolinium to evaluate for vestibular schwannoma, not another audiogram.

Pure-tone audiometry is the diagnostic gold standard:

Speech audiometry:

Tympanometry:

Screening recommendations:

Labs: not routine; consider TSH (rare), CBC, glucose/A1c, lipid panel if vascular risk; syphilis serology if otosyphilis suspected (asymmetric, fluctuating, with neuro signs)

Diagnostic Workup — Advanced and Confirmatory Studies

— Asymmetric SNHL (≥15 dB difference at 2 contiguous frequencies, or ≥10% WRS asymmetry)

— Unilateral tinnitus or unilateral hearing loss

— Sudden SNHL not recovering

— Pulsatile tinnitus (also consider CTA/MRA)

— Disproportionately poor word recognition

— Conductive or mixed loss

— Suspected otosclerosis, cholesteatoma, ossicular discontinuity, temporal bone trauma, superior canal dehiscence

— Tests neural conduction along CN VIII to brainstem

— Used when MRI contraindicated, in infants, or to confirm retrocochlear pathology

— Newborn hearing screening uses automated ABR or otoacoustic emissions (OAEs)

— Reflect outer hair cell function; absent in cochlear damage and noise/ototoxic injury

— Useful in pediatric screening and in suspected functional/non-organic hearing loss

— Autoimmune inner ear disease workup: ANA, ESR, CRP, RF, anti–68 kDa (HSP-70); suspect in rapidly progressive bilateral SNHL responsive to steroids

— FTA-ABS/RPR for otosyphilis

— Lyme serology in endemic exposures

Step 3 management: A 68-year-old man with 6 months of progressive right-sided hearing loss, right tinnitus, and 60% word recognition on the right vs 92% on the left — next best step is MRI IAC with contrast, looking for vestibular schwannoma (cerebellopontine angle tumor); do not attribute asymmetric loss to presbycusis.

MRI internal auditory canal (IAC) with gadolinium — indicated when:

CT temporal bone — when:

Auditory Brainstem Response (ABR):

Otoacoustic emissions (OAEs):

Vestibular testing (VNG, vHIT, rotary chair) — if vertigo accompanies hearing loss

Genetic testing: consider in early-onset/familial SNHL (GJB2/Connexin 26 most common; not for typical presbycusis)

Specialty labs when atypical:

Management Logic — From Diagnosis to Intervention

— Mild loss + minimal functional impact → counseling, communication strategies, annual reassessment

— Moderate or greater loss, or significant functional/social/cognitive impact → hearing aid candidacy evaluation

— Remove cerumen impaction

— Discontinue or substitute ototoxic medications where possible (e.g., switch aminoglycoside, reduce furosemide dose)

— Treat middle ear effusion, otitis externa

— Optimize comorbidities (DM, HTN, smoking cessation) — vascular health correlates with cochlear preservation

— Communication strategies & environmental modification: face the patient, reduce background noise, good lighting for lip-reading, slower speech (not louder), captioned phones, TV listening systems

— Personal sound amplification products (PSAPs) and OTC hearing aids (FDA-approved category since 2022) for mild–moderate perceived loss in adults ≥18; bypass need for prescription/audiologist

— Prescription hearing aids fitted by audiologist for moderate–severe loss; best outcomes with binaural fitting + real-ear verification

— Assistive listening devices (FM systems, loop systems, captioned phones, smoke alarms with strobes)

— Cochlear implant for severe-to-profound bilateral SNHL with poor benefit from hearing aids (AzBio sentence score ≤60% in best-aided condition); Medicare-covered

— Bone-anchored hearing aids (BAHA) for single-sided deafness or conductive/mixed loss

Board pearl: The ACHIEVE trial (2023) showed hearing aids slowed 3-year cognitive decline by ~48% in older adults at increased risk for dementia — strengthens the case for active treatment, not just observation, in cognitively vulnerable patients.

Confirm diagnosis with audiometry, then stratify by severity and impact:

Address reversible contributors first:

Tiered intervention ladder:

Cost & access: traditional hearing aids $2,000–6,000/pair, often not covered by Medicare Part B; OTC aids $200–1,000

Pharmacotherapy and Non-Device Therapy

— Do not prescribe ginkgo biloba, vitamin/mineral combinations, or "vascular" agents — no proven benefit

— Statins, antihypertensives may indirectly preserve cochlear vascular supply but are not prescribed for hearing loss

— Aminoglycosides (gentamicin, tobramycin, amikacin): cumulative dose-related cochleotoxicity and vestibulotoxicity; monitor troughs, limit duration, baseline + serial audiograms when >5–7 days

— Platinum chemotherapy (cisplatin > carboplatin): irreversible high-frequency SNHL; pre-treatment audiogram, sodium thiosulfate (FDA-approved 2022) reduces cisplatin ototoxicity in pediatric solid tumors

— Loop diuretics at high IV doses (furosemide bolus in CKD): usually reversible; prefer infusion

— High-dose salicylates (>3 g/day): reversible tinnitus and hearing loss

— Macrolides (azithro, erythro) at high IV doses: reversible

— Quinine, chloroquine, hydroxychloroquine: cumulative

— Vancomycin: ototoxicity risk overstated; primarily synergistic with aminoglycosides

— Onset <72 h, ≥30 dB drop across 3 contiguous frequencies → otologic emergency

— Oral prednisone 1 mg/kg/day × 10–14 days (taper), or intratympanic dexamethasone

— Best outcomes if treated within 2 weeks; refer ENT same/next day

— Obtain MRI IAC to rule out vestibular schwannoma (~1% of cases)

— Cognitive behavioral therapy (best evidence), tinnitus retraining therapy, sound enrichment, treat coexisting depression/anxiety

— Avoid benzodiazepines chronically

Key distinction: Presbycusis ≠ sudden SNHL. Steroids have no role in chronic presbycusis, but are first-line for idiopathic sudden SNHL — recognizing the tempo determines whether you prescribe or refer for amplification.

There is no FDA-approved pharmacologic treatment that restores or halts presbycusis — this is a high-yield Step 3 negative

Ototoxic drug stewardship — the only "medication management" that matters:

Sudden SNHL (different entity, often confused on exam):

Tinnitus management (often coexists):

Hearing Aids, Cochlear Implants, and Procedural Management

— For adults ≥18 with perceived mild-to-moderate hearing loss

— No prescription, exam, or fitting required; purchased directly

— Cost $200–1,000; better access for low-income and rural patients

— Counsel: red flags requiring medical evaluation before OTC purchase — sudden loss, unilateral loss, pain, drainage, dizziness, tinnitus, recent trauma

— Fitted by audiologist; styles include BTE, RIC, ITE, ITC, CIC

— Digital signal processing, directional mics, telecoil/Bluetooth, noise reduction

— Real-ear measurement (REM) verification essential for adequate gain

— Binaural > monaural for localization and noise discrimination

— Acclimatization period 4–12 weeks; counsel realistic expectations (aids assist, not restore)

— Bilateral moderate-to-profound SNHL with limited benefit from optimally fitted hearing aids

— Adult criterion: best-aided AzBio sentence score ≤60% in ear to be implanted, ≤60% bilaterally (Medicare ≤40% traditionally, expanded in 2022)

— Pre-op: audiology, ENT, imaging (CT/MRI), psych eval, vaccination — pneumococcal vaccine (PCV20 or PCV15+PPSV23) required ≥2 weeks pre-op to reduce meningitis risk

— Post-op activation 2–4 weeks; auditory rehab essential

— Single-sided deafness, conductive/mixed loss, chronic ear drainage precluding conventional aids

Board pearl: Before cochlear implantation, pneumococcal vaccination is mandatory — implant recipients have markedly elevated risk of pneumococcal meningitis. Step 3 loves this preventive medicine intersection.

OTC hearing aids (FDA category since Oct 2022):

Prescription hearing aids:

Cochlear implant (CI) candidacy:

Bone-anchored hearing systems (BAHA, Ponto):

Middle ear implants and active transcutaneous devices for select cases

Stapedectomy/stapedotomy — not for presbycusis; for otosclerosis (conductive loss, paracusis of Willis, Schwartze sign)

Special Populations — Elderly and Renal/Hepatic Impairment

— Hearing loss is independently linked to falls (each 10 dB loss → ~1.4× fall risk), dementia (moderate loss ~3× risk), depression, social isolation, hospital readmissions, and mortality

— Screen for hearing in any older adult with cognitive complaints, falls, depression, or "noncompliance" — uncorrected hearing loss masquerades as all of these

— Include hearing assessment in annual Medicare Wellness Visit and in Comprehensive Geriatric Assessment

— Dexterity and vision matter for hearing aid use — counsel rechargeable models, larger controls, smartphone apps

— Cognitive load: hearing impairment increases "listening effort" → fatigue, withdrawal, apparent slowing

— Older adults often on multiple ototoxic drugs (loop diuretics for CHF, aminoglycosides for UTI/sepsis, hydroxychloroquine for RA)

— Renal impairment amplifies ototoxicity of aminoglycosides, vancomycin, cisplatin, loop diuretics — adjust doses, monitor levels, prefer non-ototoxic alternatives (e.g., ceftriaxone over gentamicin where appropriate)

— In hepatic impairment, fewer direct ototoxicity issues, but altered drug metabolism may increase exposure to ototoxic agents

— Higher prevalence of SNHL — shared cochlear/renal microvascular and ion transport pathology (cochlear stria vascularis ↔ renal tubular epithelium)

— Avoid concurrent IV loop diuretic + aminoglycoside; if unavoidable, use prolonged infusion of loop and once-daily aminoglycoside with strict trough monitoring

— Dialysis patients: monitor audiograms periodically if on long-term ototoxic exposure

Step 3 management: An 82-year-old with CHF on furosemide who needs treatment for pseudomonal pneumonia — prefer antipseudomonal beta-lactam (cefepime, pip-tazo) over aminoglycoside, separate timing of loop diuretic boluses, and obtain baseline audiogram if extended therapy anticipated.

Geriatric considerations:

Polypharmacy review:

CKD and ESRD:

Frailty: weigh burden of cochlear implant surgery against expected benefit; even severely frail patients often benefit from amplification with appropriate support

Special Populations — Pediatrics, Pregnancy, and Workplace

— Universal newborn hearing screening (UNHS) mandated in all US states — OAEs and/or automated ABR before hospital discharge

— EHDI 1-3-6 rule: screen by 1 month, diagnose by 3 months, intervene by 6 months

— Failed screen → diagnostic ABR; congenital causes: cCMV (most common non-genetic), GJB2/Connexin 26 (most common genetic), prematurity, hyperbilirubinemia, ototoxic exposures, TORCH

— School-age: language delay, behavioral problems, school underperformance — get audiogram

— Rising prevalence of noise-induced hearing loss (NIHL) from personal audio devices; counsel 60/60 rule (≤60% volume, ≤60 minutes), noise-canceling > louder volume

— High-frequency notch at 4000 Hz classic for NIHL

— Otosclerosis can accelerate during pregnancy (estrogen-mediated) — conductive loss, may need stapedectomy postpartum

— Avoid ototoxic drugs (aminoglycosides cross placenta, can cause fetal SNHL; streptomycin classically)

— Sudden SNHL in pregnancy: treat with steroids if benefits outweigh risks (prednisone category C historically; generally used)

— OSHA: hearing conservation program required when 8-hr TWA ≥85 dBA — annual audiograms, hearing protection, training

— Standard threshold shift (STS) = 10 dB average shift at 2, 3, 4 kHz from baseline → requires intervention

— Military/veterans: tinnitus and hearing loss are top VA service-connected disabilities — refer to VA audiology

Board pearl: A toddler with delayed speech and a history of NICU stay with gentamicin exposure — next step is formal audiologic evaluation (diagnostic ABR), even if newborn screen "passed," because postnatal ototoxic and acquired losses are missed by UNHS.

Pediatric hearing loss (contextually relevant for differential):

Adolescents and young adults:

Pregnancy:

Occupational/military exposures:

Musicians, first responders, dentists: custom musician earplugs preserve fidelity while reducing dB

Complications and Adverse Outcomes

— Lancet Commission lists untreated mid-life hearing loss as the single largest modifiable dementia risk factor (~8% of attributable risk)

— Mechanisms: cognitive load hypothesis, sensory deprivation, social isolation, shared neurodegeneration

— ACHIEVE trial: hearing aid use slowed cognitive decline in high-risk older adults over 3 years

— Each 10 dB loss → ~1.4× risk of falls; reduced auditory awareness of environment, increased postural control load

— Falls drive hip fractures, head injury, hospitalization, loss of independence

— ~2× risk of depression; reduced participation in family/community

— Screen with PHQ-9; treat depression and amplification together

— Misunderstood medication instructions → adherence errors, adverse drug events

— Misdiagnosis of dementia when patient cannot hear cognitive screening questions

— Patient safety event: failure to provide amplification/written instructions during informed consent

— Untreated hearing loss correlated with lower wages and earlier retirement

— Insomnia, anxiety, rare suicidality in severe cases

— Device failure, facial nerve injury (rare), vestibular dysfunction, meningitis (pneumococcal — vaccinate), wound issues, tinnitus

— Cerumen impaction from occlusion, otitis externa, feedback, fit discomfort, abandonment (~30% within 1 year if unsupported)

Key distinction: "Cognitive impairment" in a hearing-impaired patient should prompt repeating cognitive testing with amplification or written prompts before diagnosing dementia — uncorrected hearing loss can drop MMSE/MoCA scores by 2–4 points purely from input failure, not true cognitive deficit.

Cognitive decline and dementia:

Falls and injury:

Depression, anxiety, and social isolation:

Communication failures in healthcare:

Reduced employment and income:

Tinnitus-related morbidity:

Cochlear implant complications:

Hearing aid complications:

When to Escalate Care — Referral and Urgent Pathways

— Sudden SNHL (≥30 dB drop across 3 contiguous frequencies over ≤72 h) — treat with oral steroids while arranging audiogram and ENT within days; window for recovery is ~2 weeks

— Hearing loss after head trauma (consider temporal bone fracture)

— Hearing loss with facial weakness, vertigo, or neurologic deficit

— Acute otitis externa with necrotizing features in diabetics (malignant otitis externa) — IV antipseudomonals

— Asymmetric SNHL or unilateral tinnitus → MRI IAC and ENT

— Conductive or mixed hearing loss on audiometry

— Chronic ear drainage, suspected cholesteatoma

— Recurrent otitis media in adults

— Suspected otosclerosis (young adult, conductive loss, paracusis of Willis, family history)

— Failure to benefit from optimally fitted hearing aids → CI evaluation

— Symptomatic hearing concerns, hearing aid fitting/adjustment, vestibular evaluation, tinnitus management

— Pulsatile tinnitus with bruit → MRA/CTA, consider dural AV fistula, glomus tumor, carotid stenosis

— If admitting an elderly patient: document baseline hearing/aid use, ensure aids brought to bedside, place visible signage, use pocket talkers, provide written instructions, involve family for goals-of-care discussions

CCS pearl: Admitting a 78-year-old for pneumonia — your CCS order set should include "hearing aids to bedside, batteries available" and "use amplified communication device for rounds and consent." Forgetting this leads to delirium misdiagnosis, missed consent, and poor patient experience scores.

Urgent/same-day ENT referral:

Routine ENT referral (within weeks):

Audiology referral (direct access under Medicare since 2023 for non-acute assessment):

Neurology/neuroradiology:

Hospital/inpatient considerations (CCS thinking):

Key Differentials — Same-Category (Other Causes of SNHL)

— Bilateral SNHL with characteristic 4000 Hz notch on audiogram (recovers slightly at 8000 Hz)

— History of occupational, recreational, military exposure

— Often coexists with presbycusis ("sociocusis")

— Aminoglycosides, cisplatin, loop diuretics, salicylates, quinine

— High-frequency loss; cisplatin/aminoglycosides irreversible

— Unilateral progressive SNHL, unilateral tinnitus, disproportionate WRS, possible vertigo/imbalance, facial numbness late

— MRI IAC diagnostic; treatments: observation, stereotactic radiosurgery, microsurgery

— NF2 if bilateral schwannomas — autosomal dominant

— Triad: episodic vertigo (≥20 min, often hours), fluctuating low-frequency SNHL, tinnitus, aural fullness

— Treatment: low salt, diuretics, betahistine (outside US), intratympanic steroids/gentamicin, endolymphatic sac surgery

— Rapidly progressive (weeks–months) bilateral asymmetric SNHL, often steroid-responsive

— Associated with systemic autoimmunity (GPA, Cogan syndrome, SLE, RA)

Board pearl: Asymmetric SNHL = MRI IAC until proven otherwise. The most-tested "don't miss" diagnosis hiding behind apparent presbycusis is a vestibular schwannoma — even small ones threaten facial nerve and life if untreated.

Noise-induced hearing loss (NIHL):

Ototoxic medication-induced loss:

Vestibular schwannoma (acoustic neuroma):

Ménière disease:

Autoimmune inner ear disease (AIED):

Otosyphilis, Lyme, viral cochleitis (mumps, measles, CMV, HSV, HIV)

Vascular: AICA stroke (unilateral SNHL + vertigo + cerebellar signs)

Genetic/late-onset hereditary SNHL (DFNA, mitochondrial)

Perilymphatic fistula: post-trauma/barotrauma, fluctuating SNHL + vertigo

Key Differentials — Other-Category (Conductive and Mixed Causes)

— Most common reversible cause; conductive loss, sensation of fullness

— Treat: cerumenolytics (carbamide peroxide, mineral oil), irrigation (avoid if perforation), curette under direct visualization

— Persistent middle ear fluid → conductive loss, tympanogram type B with normal canal volume

— Adults with unilateral persistent OME → exclude nasopharyngeal carcinoma (especially in Asian patients or smokers) via flexible nasopharyngoscopy

— Otalgia, otorrhea, TM changes

— Conductive loss proportional to size and location

— Retraction pocket with squamous debris, often foul-smelling otorrhea, conductive loss, can erode ossicles → mixed loss; surgical removal

— Young/middle-aged adults, often female, family history; conductive loss progressing to mixed; Carhart notch at 2000 Hz on bone conduction; Schwartze sign (reddish promontory)

— Treatment: stapedectomy/stapedotomy or hearing aid

— Autophony, Tullio phenomenon (sound-induced vertigo), pulsatile tinnitus, conductive hyperacusis (hears own eye movement); CT temporal bone

— Otitis externa, exostoses, foreign body, EAC carcinoma

Key distinction: Conductive loss → air–bone gap on audiometry + abnormal Rinne (BC>AC) + Weber to affected ear. Sensorineural loss → no gap, Rinne AC>BC bilaterally, Weber to better ear. Mixed loss has both elements. Always classify the audiogram before choosing imaging or referral.

Cerumen impaction:

Otitis media with effusion (OME):

Acute and chronic otitis media:

Tympanic membrane perforation:

Cholesteatoma:

Otosclerosis:

Ossicular discontinuity (post-trauma): conductive loss with type Ad tympanogram

Superior canal dehiscence:

External auditory canal pathology:

Long-Term Plan, Discharge, and Secondary Prevention

— Establish audiologic baseline and repeat audiogram every 1–3 years, sooner if progression

— Initiate or optimize amplification — hearing aids (OTC or prescription) with realistic counseling

— Treat coexisting tinnitus (sound therapy, CBT)

— Address comorbid depression, cognitive concerns, fall risk

— Noise protection: foam plugs (NRR 29 dB), custom musician plugs, electronic shooting muffs; avoid sustained >85 dBA exposure; use 60/60 rule for personal audio

— Tobacco cessation — smoking accelerates SNHL via cochlear vascular injury

— Optimize vascular risk: BP <130/80, LDL per ASCVD risk, A1c per ADA, weight management

— Avoid ototoxic drugs where alternatives exist; if required, baseline + serial audiograms

— Pneumococcal vaccination per ACIP — particularly important if cochlear implant planned (PCV20 or PCV15→PPSV23 ≥2 weeks before surgery)

— Annual influenza vaccine reduces risk of viral cochleitis indirectly

— Document hearing aid status and ensure devices and batteries go home

— Provide written discharge instructions; teach-back with family present

— Schedule follow-up audiology/ENT if new hearing concerns identified during admission

— Reconcile medications for ototoxic agents added during hospitalization

— Primary care: longitudinal hearing surveillance, comorbidity optimization

— Audiology: device fitting, REM verification, annual checks

— ENT: surgical candidates, atypical or asymmetric loss

— Social work: assistive device funding (state vocational rehab, Lions Club, Veterans benefits)

Step 3 management: Patient newly fitted with hearing aids — schedule audiology follow-up at 2–4 weeks for fine-tuning and at 3 months to assess real-world benefit; abandonment rates fall sharply with structured follow-up vs. fit-and-release.

Long-term management plan for confirmed presbycusis:

Secondary prevention — slow further loss:

Hospital discharge considerations (CCS-relevant):

Care coordination:

Follow-Up, Monitoring, and Aural Rehabilitation

— Stable presbycusis: audiogram every 1–3 years

— On ototoxic therapy: baseline, then per protocol (e.g., before each cisplatin cycle, weekly with prolonged aminoglycosides)

— Noise-exposed workers: annual OSHA audiogram

— After cochlear implant: routine mapping at 1, 3, 6, 12 months, then annually

— Initial fitting → 2–4 week check (comfort, gain, REM)

— 3-month outcome assessment (validated tools: IOI-HA, APHAB)

— Annual cleaning, reprogramming, battery/wax filter management

— Replacement typically every 5–7 years

— Group AR programs improve hearing-aid benefit and reduce social handicap (HHIE-S scores)

— Components: auditory training, speechreading, communication strategy education, counseling, peer support

— LACE (Listening and Communication Enhancement) and similar computerized programs

— Speak face-to-face, get attention first, slow down (don't shout), reduce background noise, rephrase rather than repeat

— Encourage social engagement; isolation worsens cognition and mood

— Smoke alarms with strobes/bed-shakers; doorbell amplifiers; captioned telephones (free via national programs for those with documented hearing loss)

— Rescreen cognition after amplification optimization — improvements suggest prior scores were artifactually low

— Screen PHQ-9 annually; treat depression

— No formal restriction for hearing loss alone in most states, but counsel on use of visual scanning and avoiding distractions

Board pearl: Validated patient-reported outcome tools (HHIE-S, IOI-HA, APHAB) drive value-based care metrics for hearing rehab — using them at baseline and 3 months objectively documents benefit and justifies device coverage.

Audiologic monitoring cadence:

Hearing aid follow-up:

Aural rehabilitation (AR):

Patient/family counseling:

Cognitive and mood reassessment:

Driving safety:

Ethical, Legal, and Patient Safety Considerations

— Consent is invalid if the patient cannot hear/understand the discussion

— Provide hearing aids, pocket talkers, written materials, certified sign language interpreters (for Deaf patients); lip-reading family members are not sufficient for complex consent

— ADA and Section 504 require healthcare facilities to provide effective communication accommodations at no cost to the patient — failure is both ethical and legal exposure

— Apparent confusion in a hearing-impaired older adult may be communication failure, not incapacity — optimize hearing before formal capacity evaluation

— Hearing-impaired patients are at higher risk of medication errors after discharge — use teach-back, written instructions, pillboxes, involve caregivers

— ED handoffs: ensure hearing aids accompany the patient between facilities; lost hearing aids during admission are a common, costly adverse event

— Counsel on situational awareness; CDL drivers must meet DOT hearing standards (whisper at 5 ft or audiometric criteria)

— Pilots, military, law enforcement have job-specific hearing standards

— Employers must provide hearing conservation programs at TWA ≥85 dBA — failure may be reportable

— Cochlear implantation in Deaf children is debated within Deaf cultural community; family-centered, culturally sensitive counseling required

— Traditional Medicare does not cover hearing aids; Medicare Advantage plans often do; OTC hearing aids and direct audiologist access improve equity but cost remains a barrier

Step 3 management: Before obtaining surgical consent from an 80-year-old with severe presbycusis, ensure hearing aids are in place or use an amplification device, provide written summary, document teach-back — without these, consent may be legally and ethically deficient.

Informed consent and effective communication:

Capacity assessment:

Patient safety in transitions of care:

Driving and occupational safety:

OSHA and workplace ethics:

Pediatric ethics:

Insurance/access disparities:

Research ethics: informed consent for clinical trials requires equivalent accommodation

High-Yield Associations and Rapid-Fire Clinical Facts

Board pearl: When in doubt, audiogram first, MRI second — the audiogram tells you whether the loss is sensorineural, conductive, or mixed and whether it's symmetric, which determines whether and what to image.

Presbycusis = bilateral, symmetric, high-frequency SNHL in older adults; no air–bone gap

Most common reversible cause of hearing loss in elderly = cerumen impaction — always look first

Weber lateralizes to better ear in SNHL, to worse ear in conductive loss; Rinne AC>BC = normal or SNHL

4000 Hz notch = noise-induced hearing loss

Carhart notch at 2000 Hz on BC + conductive loss + young adult = otosclesosis

Asymmetric SNHL, poor WRS, unilateral tinnitus → MRI IAC with gadolinium for vestibular schwannoma

Bilateral vestibular schwannomas = NF2 (chromosome 22)

Episodic vertigo + low-frequency SNHL + tinnitus + aural fullness = Ménière disease

Sudden SNHL = otologic emergency — oral steroids, ENT within days, MRI IAC

Universal newborn hearing screening: 1-3-6 rule (screen 1 mo, diagnose 3 mo, intervene 6 mo)

Most common non-genetic cause of congenital SNHL = cCMV; most common genetic = Connexin 26 (GJB2)

OTC hearing aids: FDA approved 2022, adults ≥18, perceived mild-moderate loss

Cochlear implant: severe-to-profound bilateral SNHL, AzBio ≤60% best-aided; pneumococcal vaccine required pre-op

ACHIEVE trial 2023: hearing aids slowed cognitive decline ~48% in at-risk older adults

Lancet Commission: mid-life untreated hearing loss = largest modifiable dementia risk factor

Each 10 dB hearing loss → ~1.4× fall risk

USPSTF (2021): insufficient evidence to recommend routine screening in asymptomatic adults ≥50 — but case-finding encouraged

Medicare 2023: direct access to audiologists for non-acute hearing assessment without physician order

OSHA hearing conservation: TWA ≥85 dBA triggers requirements

Tinnitus + hearing loss = top VA service-connected disabilities

Cisplatin ototoxicity reducer: sodium thiosulfate (pediatric solid tumors, 2022)

Pregnancy → otosclerosis may accelerate

Pulsatile tinnitus → image vasculature (MRA/CTA)

Persistent unilateral OME in adult → rule out nasopharyngeal carcinoma

Board Question Stem Patterns

Step 3 management: When the stem provides a clear "asymmetric or sudden" feature, the correct answer is rarely "reassure" — it is audiogram + MRI or steroids + urgent ENT. Reflex these patterns.

Classic presbycusis stem: 74-year-old reports difficulty understanding conversation in restaurants, family says he turns TV up. Otoscopy normal, Weber midline, Rinne AC>BC bilaterally. Next step → audiometry; management → hearing aid evaluation

Cerumen masquerade: Elderly patient with new hearing loss; otoscopy shows occluding cerumen. Next step → cerumen removal, then reassess before further workup

Sudden SNHL trap: 55-year-old wakes with unilateral hearing loss and tinnitus 2 days ago. Next step → audiogram + oral prednisone + ENT referral + MRI IAC — do NOT defer as presbycusis

Vestibular schwannoma stem: 60-year-old with 6 months of progressive right hearing loss, right tinnitus, mild imbalance. WRS 40% right vs 90% left. Next step → MRI internal auditory canal with gadolinium

Otosclerosis stem: 35-year-old woman with progressive bilateral hearing loss worse during pregnancy, hears better in noisy rooms (paracusis of Willis), Carhart notch. Diagnosis → otosclerosis; treatment → stapedectomy or hearing aid

Ménière stem: Recurrent episodes of vertigo lasting hours with low-frequency fluctuating hearing loss, tinnitus, aural fullness. First-line → low-salt diet ± diuretic

Ototoxicity stem: Patient on cisplatin develops high-frequency hearing loss; prevention/monitoring → baseline and pre-cycle audiograms; sodium thiosulfate in pediatric solid tumors

Cognitive screening pitfall: Older adult scores low on MoCA, family confirms hearing trouble. Next step → repeat cognitive testing with amplification before diagnosing dementia

Cochlear implant prep: Severe-to-profound bilateral SNHL, hearing aid no benefit. Required pre-op → pneumococcal vaccination ≥2 weeks before surgery

Pediatric stem: Failed newborn hearing screen. Next step → diagnostic ABR by 3 months; intervention by 6 months

NIHL stem: 45-year-old factory worker with 4000 Hz notch bilaterally. Management → hearing protection, OSHA-mandated conservation program, annual audiograms

Persistent unilateral adult OME: Asian patient with chronic unilateral middle ear effusion. Next step → flexible nasopharyngoscopy to evaluate for nasopharyngeal carcinoma

One-Line Recap

Presbycusis is the bilateral, symmetric, high-frequency sensorineural hearing loss of aging, diagnosed by audiometry after excluding reversible causes (cerumen, ototoxic drugs) and red flags (sudden, asymmetric, or neurologic features), and managed primarily with amplification — OTC or prescription hearing aids, escalating to cochlear implants for severe-to-profound loss — to preserve cognition, prevent falls, and maintain social engagement.

Board pearl: If you remember one thing — audiogram first, image asymmetric or retrocochlear patterns, treat with amplification, and never blame a sudden or unilateral loss on "just aging."

Diagnosis: bilateral, symmetric, gradual high-frequency SNHL with no air–bone gap; Weber midline, Rinne AC>BC bilaterally; confirm with pure-tone + speech audiometry; rule out cerumen first

Red flags demanding workup beyond presbycusis: sudden SNHL (steroids + urgent ENT), asymmetric loss or poor WRS (MRI IAC for vestibular schwannoma), conductive component (CT temporal bone, ENT), vertigo/fluctuation (Ménière workup)

Treatment ladder: communication strategies → OTC hearing aids (mild–moderate, perceived loss, adults ≥18) → prescription hearing aids with audiology fitting and REM verification → cochlear implant for severe-to-profound bilateral SNHL with poor aided benefit (AzBio ≤60%) — pneumococcal vaccination required pre-implant

Why it matters: untreated hearing loss is the largest modifiable dementia risk factor (Lancet Commission), drives falls, depression, isolation, and medication errors; ACHIEVE trial showed hearing aids slow cognitive decline; USPSTF gives an I statement for routine screening but case-finding via a single question and HHIE-S is universally endorsed; document hearing status, ensure aids accompany hospitalized patients, and verify communication accommodations for valid informed consent